US2007099932A1PendingUtilityA1
External preparation for athlete's foot treatment
Est. expiryJun 25, 2023(expired)· nominal 20-yr term from priority
A61P 43/00A61P 31/10A61P 29/00A61P 31/00A61K 31/27A61K 31/185A61K 47/22A61P 17/00A61K 31/167A61P 23/00A61K 31/4402A61K 31/137A61K 31/047A61K 31/47A61K 31/045A61P 23/02A61K 31/56A61K 9/0014A61K 45/06A61K 31/05
37
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
External preparations for athlete's foot treatment capable of enhancing patient's compliance and capable of reducing the symptom of rube faction, comprising an anti- trichophton drug mixed with at least one compound selected from among 1-menthol, menthol analogue compounds and bactericidal compounds.
Claims
exact text as granted — not AI-modified1 . An external preparation for athlete's foot treatment, comprising an anti- trichophyton drug mixed with at least one compound selected from l-menthol, menthol analogue compounds and bactericidal compounds.
2 . The external preparation for athlete's foot treatment according to claim 1 , wherein the anti- trichophton drug and at least one compound selected from l-menthol, menthol analogue compounds and bactericidal compounds are blended in 0.1-10% by mass and 0.5-5% by mass respectively.
3 . The external preparation for athlete's foot treatment according to claim 1 , wherein the menthol analogue compound is 3-1-menthoxypropane-1,2-diol.
4 . The external preparation for athlete's foot treatment according to claim 1 , wherein the bactericidal compound is isopropylmethylphenol.
5 . The external preparation for athlete's foot treatment according to claim 1 , wherein the anti- trichophton drug is selected from benzylamine type, allylamine type, thiocarbamic acid type and imidazole type antifungal agents.
6 . The external preparation for athlete's foot treatment according to claim 1 , wherein the anti- trichophton drug is one kind selected from butenafine hydrochloride, terbinafine hydrochloride, tolnaftate, bifonazole, ketoconazole, neticonazole hydrochloride and lanoconazole.
7 . The external preparation for athlete's foot treatment according to claim 1 , wherein the anti- trichophton drug and l-menthol are blended.
8 . The external preparation for athlete's foot treatment according to claim 1 comprising the anti- trichophton drug, l-menthol and the bactericidal compound, wherein the anti- trichophton drug is butenafine hydrochloride, the bactericidal compound is isopropylmethylphenol, and the butenafine hydrochloride l-menthol and isopropylmethylphenol are blended.
9 . The external preparation for athlete's foot treatment according to claim 1 , further comprising at least one kind of a local anesthetic, an antihistamine and an anti-inflammatory drug.
10 . The external preparation for athlete's foot treatment according to claim 9 , wherein the local anesthetic is dibucaine hydrochloride, or lidocaine or its salt.
11 . The external preparation for athlete's foot treatment according to claim 9 , wherein the antihistamine is chlorpheniramine maleate, or diphenhydramine or its salt.
12 . The external preparation for athlete's foot treatment according to claim 9 , wherein the anti-inflammatory drug is glycyrrhetinic acid or its salt, or allantoin.
13 . The external preparation for athlete's foot treatment according to claim 9 comprising the anti- trichophton drug, l-menthol, local anesthetic, antihistamine and the anti-inflammatory drug, wherein the anti- trichophton drug is butenafine hydrochloride, the local anesthetic is dibucaine hydrochloride, the antihistamine is chlorpheniramine maleate, and the anti-inflammatory drug is glycyrrhetinic acid, and the butenafine hydrochloride, l-menthol, dibucaine hydrochloride, chlorpheniramine maleate and glycyrrhetinic acid are blended.Join the waitlist — get patent alerts
Track US2007099932A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.